Skip Navigation

JNCI Journal of the National Cancer Institute 1990 82(10):868-873; doi:10.1093/jnci/82.10.868
© 1990 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Nelson, J. S.
Right arrow Articles by Berns, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, J. S.
Right arrow Articles by Berns, M. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 82, No. 10, 868-873, May 16, 1990
© 1990 Oxford University Press

Use of Multiple Photosensitizers and Wavelengths During Photodynamic Therapy: A New Approach To Enhance Tumor Eradication

J. Stuart Nelson*, Lih-Huei L. Liaw, Robert A. Lahlum, Paul L. Cooper, Michael W. Berns

Beckman Laser Institute and Medical Clinic, University of California Irvine, Irvine, CA

*Correspondence to: J. Stuart Nelson, M.D., Ph.D., Beckman Laser Institute and Medical Clinic, University of California, Irvine, 1002 Health Sciences Rd. E., Irvine, CA 92715.

Several studies have examined the syn-ergism of hyperthermia or chemotherapy agents in combination with photo-dynamic therapy (PDT) to enhance tumor eradication. In our unique approach to treatment, multiple photosen-sitizers and wavelengths were used: two photosensitizers, Photofrin II and meso-tetra-(4-sulfonatophenyl)-por-phine (TPPS4), irradiated at the appropriate therapeutic wavelength for each photosensitizer. EMT-6 mammary tumors were induced in the flanks of BALB/c mice. The mice were assigned to a control group (50 mice) or treatment group (150 mice). All treatment animals and some control animals received photosensitizing drug (5 mg/kg of TPPS4, 5 mg/kg of Photofrin II, or 2.5 mg/kg of both TPPS4 and Photofrin II). All treatment animals and some control animals also received light treatment (630 nm for TPPS4 and/or 658 nm for Photofrin II). The results show that the approach using both drugs and the corresponding therapeutic wavelengths enhanced the effectiveness of PDT. This approach achieved a cure rate of up to 100%, which was, depending on the light intensity used, as much as 40% greater than the rate achieved by the approach using one drug and one wave-length. The results also show that lesser amounts of drug and/or light may be required if both drugs and wavelengths are used, thus lowering the chances of side effects common to PDT. Furthermore, the results indicate that the increased tumor kill is due to a synergistic effect of the two photosensitizers that was tested on the tumor microvascula-ture in the first few hours after PDT. [J Natl Cancer Inst 82:868–873, 1990]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
Q. Peng, T. Warloe, J. Moan, A. Godal, F. Apricena, K.-E. Giercksky, and J. M. Nesland
Antitumor Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy Can Be Enhanced by the Use of a Low Dose of Photofrin in Human Tumor Xenografts
Cancer Res., August 1, 2001; 61(15): 5824 - 5832.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.